SUPERNUS PHARMACEUTICALS, INC. (SUPN) Net margin 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) net profit margin by fiscal year — reported net income divided by reported revenue.
-5.4%FY2025 · since FY2016: 42.4% → -5.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.4% | -16.5 pp |
| FY2024 | 11.2% | +11.0 pp |
| FY2023 | 0.2% | -8.9 pp |
| FY2022 | 9.1% | -0.1 pp |
| FY2021 | 9.2% | -15.2 pp |
| FY2020 | 24.4% | -4.4 pp |
| FY2019 | 28.8% | +1.6 pp |
| FY2018 | 27.1% | +8.2 pp |
| FY2017 | 19.0% | -23.5 pp |
| FY2016 | 42.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice